Microbial lipase sales will strengthen through 2036, anchored by fungi at a 46.0% share in 2026 as the leading source segment. The market is expected to reach USD 697.9 million in 2026 and USD 1347.5 million by 2036, creating an absolute dollar opportunity of USD 649.6 million between 2026 and 2036.